Építés alatt – nem éles oldal
Belépés
Résztvevőt keres2/3. fázis

Efficacy of Hyperbaric oxygen in addition to standard treatment for acute sudden deafness

A legfontosabb adatok

Fázis
2/3. fázis

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
Helse Bergen HF
Azonosító
EU 2024-510798-84-00
A regiszteradat frissítve
2026. november 6.
Eredeti leírás
To assess if the addition of HBOT to standard care leads to better hearing 3 months after treatment than treatment with standard care only.A teljes eredeti leírásKevesebb

Hyperbaric oxygen treatment added to standard care for acute idiopathic sudden sensorineural hearing loss - a multicentre randomized controlled trial

To assess if the addition of HBOT to standard care leads to better hearing 3 months after treatment than treatment with standard care only.

Bevonási feltételek: 18 to 80 years of age; Onset of acute hearing loss no longer than 7 days ago; HBO can be started within 7 days from symptom onset; Pure tone audiometry shows sensorineural hearing loss with at least 30dB loss in three consecutive frequencies; Idiopathic sensorineural hearing loss is the most probable diagnosis according to clinical judgement; The hearing threshold is 50 dB or more in PTA (based on 0,5kHz, 1kHz, 2kHz, 4kHz).

Kizáró feltételek: Any contraindication to treatment with hyperbaric oxygen: - COPD, asthma or other lung disease with severely reduced lung function corresponding to GOLD III (spirometry shows FEV1 <50% of expected) - Asthma not well regulated on oral basic medication and/or with attacks within the last year - Current pneumonia or <4 weeks from complete recovery - X-ray showing emphysema-bulla or non-static atelectasis - Severe cardiac failure, instable angina, cardial infarction <6 months ago - Ongoing use of Disulfiram (Antabus ®) - Earlier treatment with Bleomycin (any time) - Artificial middle ear bones - Pregnancy; Not idiopathic sudden sensorineural hearing loss, but another disease, injury or condition is most likely the cause of the current hearing loss; Cognitive or language barriers that hamper adherence to the study protocol 3. Major; Major alcohol abuse.

EU CTIS 2024-510798-84-00